Ann: ASX Relisting and Market Update, page-11

40,000 units x $50 = $24 million per year based on $50 per month per unit as in the presentations.
Not sure what the 500k pre sales pipeline is based on when they are using a subscription model. Anybody have some ideas?

The ability to get these pulse units into customers hands is what will determine where the price goes in my opinion. The previous roadblocks of cash are non-existent for the next 6-12 months at least.

Still intrigued about the band.If somehow they could get FDA approval for that would be unbelievable for the share price.
Successful clinical validation of the CONNEQT Band technology (as a pre-cursor to regulatory
approval being sought - anticipated to be July 2024);

.